Dr Nazia Chaudhuri is a respiratory physician with a specialist interest in interstitial lung disease (ILD) service. She was the lead of the ILD service at the Manchester University NHS Foundation Trust (MFT), United Kingdom for over 9 years and has recently re located to Northern Ireland, where she aims to take up an academic post at the University of Ulster and Altnagelvin hospital. She remains an honorary senior lecturer at the University of Manchester as the academic year 3 lead for the undergraduate medical school.
She graduated from the University of Leeds with an honours degree in medicine and a BSc honours in genetics. She performed a PhD and published her work looking at the cellular interactions and signalling in response to infection and air pollution.
As an ILD specialist, Dr Chaudhuri has developed the local ILD service by enhancing the delivery of care by establishing day case model to reduce waiting times, creating a clinical database and ensuring a presence on the internet by developing a website, twitter and Facebook page. She has been instrumental in setting up and delivering a regional North West and Northern ILD network.
She is the principal investigator on a number of clinical research trials (>20 over 5 years) in idiopathic pulmonary fibrosis (IPF) and is the UK Chief Investigator of a major clinical trial on progressive ILDs and a trial in IPF. She is collaborator on a number of grants exceeding £5 million and has co-authored 41 peer reviewed articles in 5 years. She is also co-applicant for a British Lung foundation grant for a study in Sarcoidosis.
Dr Chaudhuri has published her experience in prescribing antifibrotics and delivering MDT care and has presented many abstracts pertaining to IPF, antifibrotics and the importance of a multi-disciplinary team approach at all major respiratory conferences. She is chair of the British Thoracic Society (BTS) interstitial and rare lung disease specialist advisory group. She is also a medical adviser for the British Lung Foundation.
his theme to customize and add content to this page.
She graduated from the University of Leeds with an honours degree in medicine and a BSc honours in genetics. She performed a PhD and published her work looking at the cellular interactions and signalling in response to infection and air pollution.
As an ILD specialist, Dr Chaudhuri has developed the local ILD service by enhancing the delivery of care by establishing day case model to reduce waiting times, creating a clinical database and ensuring a presence on the internet by developing a website, twitter and Facebook page. She has been instrumental in setting up and delivering a regional North West and Northern ILD network.
She is the principal investigator on a number of clinical research trials (>20 over 5 years) in idiopathic pulmonary fibrosis (IPF) and is the UK Chief Investigator of a major clinical trial on progressive ILDs and a trial in IPF. She is collaborator on a number of grants exceeding £5 million and has co-authored 41 peer reviewed articles in 5 years. She is also co-applicant for a British Lung foundation grant for a study in Sarcoidosis.
Dr Chaudhuri has published her experience in prescribing antifibrotics and delivering MDT care and has presented many abstracts pertaining to IPF, antifibrotics and the importance of a multi-disciplinary team approach at all major respiratory conferences. She is chair of the British Thoracic Society (BTS) interstitial and rare lung disease specialist advisory group. She is also a medical adviser for the British Lung Foundation.
his theme to customize and add content to this page.